FAQ

Frequently asked questions by audience

36 Q&As on Vietnamese pharma and health regulation, organised by the audience asking. The same regulatory topic reads very differently for a foreign investor than for a pharmacist. Pick the group that fits.

Foreign investors / FIE

Foreign-invested enterprises navigating Vietnamese pharma rules — MA holding, import rights, partner notifications.

See the questions →

Distributors & wholesalers

Wholesalers and distributors — licensing, GDP, traceability, recall coordination.

See the questions →

Pharmacists & retail

Community pharmacy operators — GPP, CCHN, online sales, special-control drugs.

See the questions →

Healthcare practitioners

Doctors, nurses, midwives — CCHN KCB, CME, NMLE, three-tier system.

See the questions →

Drug companies

Drug companies — registration, GMP, renewal, reference dossier, pharmacovigilance.

See the questions →

Supplement & food companies

TPCN and food companies — NĐ 15/2018 framework (NĐ 46/2026 suspended by NQ 15/2026), declarations, HACCP, advertising.

See the questions →

Answers are reference information only, not legal advice. Always cross-check the original text before acting.